Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Program
Program note: WRAL News at 10 airs tonight on WRAL+, antenna Ch. 34.1, Spectrum 1257 or in the WRAL News app on your smart TV or mobile device
Program
New on WRAL+ at 10: Tracking Halloween festivities on Franklin Street as a spooky chill sets in. Watch WRAL+ wherever you stream WRAL.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
218.04
-10.16 (-4.45%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,825,377
Open
223.00
Bid (Size)
217.73 (1)
Ask (Size)
217.80 (3)
Prev. Close
228.20
Today's Range
216.00 - 223.87
52wk Range
163.81 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.01%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
October 31, 2025
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant...
Via
MarketMinute
Topics
Intellectual Property
Exploring the top movers within the S&P500 index during today's session.
October 31, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via
Chartmill
Performance
YTD
+21.5%
+21.5%
1 Month
-10.8%
-10.8%
3 Month
+11.7%
+11.7%
6 Month
+9.9%
+9.9%
1 Year
+7.0%
+7.0%
More News
Read More
Looking Into AbbVie Inc's Recent Short Interest
October 31, 2025
Via
Benzinga
AbbVie's Earnings Outlook
October 30, 2025
Via
Benzinga
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Supply Chain
Discover which S&P500 stocks are making waves on Friday.
October 31, 2025
Via
Chartmill
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
October 31, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
October 31, 2025
Via
Benzinga
Why AbbVie (ABBV) Shares Are Falling Today
October 31, 2025
Via
StockStory
Topics
World Trade
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
October 31, 2025
Via
Benzinga
Gapping S&P500 stocks in Friday's session
October 31, 2025
Via
Chartmill
AbbVie Q3 2025 Earnings Call Transcript
October 31, 2025
Via
The Motley Fool
Topics
Earnings
Economy
ABBVIE INC (NYSE:ABBV) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss
October 31, 2025
Via
Chartmill
AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%
October 31, 2025
Via
Investor's Business Daily
AbbVie’s (NYSE:ABBV) Q3 Sales Beat Estimates
October 31, 2025
Via
StockStory
Topics
Earnings
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
October 30, 2025
Via
Benzinga
Topics
ETFs
Railway Pension Liquidates All 1.65M CCJ Shares Worth $122.8 Million
October 30, 2025
Via
The Motley Fool
Topics
Supply Chain
AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect
October 29, 2025
Via
StockStory
Topics
Artificial Intelligence
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
October 28, 2025
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
Stocks
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
October 28, 2025
Via
The Motley Fool
Topics
Intellectual Property
1 Unpopular Stock That Deserves a Second Chance and 2 Facing Challenges
October 28, 2025
Via
StockStory
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
October 26, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More
October 27, 2025
Via
Benzinga
ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop
October 23, 2025
Via
The Motley Fool
Topics
Energy
Regulatory Compliance
Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally
October 23, 2025
Via
The Motley Fool
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 218.04
When was AbbVie last traded?
The last trade of AbbVie was at 10/31/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.